Let’s talk about one of the less glamorous parts of testosterone replacement therapy. The kind of thing that doesn't usually make it into conversations about better energy, improved libido, or the benefits of treating low testosterone.
We're talking about testicular shrinkage.
It's not exactly a topic most men are eager to bring up with their doctor. But for men on TRT, changes in testicular size are a real possibility, and they can raise some understandable questions. Is this normal? Is it permanent? And is there anything that can be done about it?
The short answer is that testosterone therapy can reduce testicular size because of the way it affects the body's natural hormone production. The good news? Healthcare providers have ways to evaluate these changes, and there are treatment options worth knowing about.
One of them is human chorionic gonadotropin, better known as HCG.
So, what's actually happening down there, and where does HCG fit into the picture?
First, a quick biology lesson. Your testicles do more than produce testosterone. They're also responsible for making sperm, and both functions rely on hormonal signals sent from the brain.
Two hormones are particularly important here: luteinizing hormone (LH) and follicle-stimulating hormone (FSH).
LH tells specialized cells in the testes to produce testosterone. FSH works alongside testosterone within the testes to support sperm production.
Under normal circumstances, the brain adjusts these signals based on the body's hormone levels. It's a feedback system designed to keep things functioning.
But when you start TRT, the equation changes.
Because testosterone is being supplied from an outside source, the brain responds by reducing its production of LH and FSH. With less hormonal stimulation reaching the testes, natural testosterone production decreases, and sperm production can decline significantly.
For some men, the resulting changes in testicular activity are accompanied by a noticeable reduction in testicular size.
How noticeable? That varies.
Some men experience relatively minor changes. Others notice a more obvious difference over time. There's no universal timeline or degree of shrinkage, and not everyone responds to testosterone therapy in exactly the same way.
The important thing to understand is that this isn't necessarily a sign that TRT isn't working. It's a recognized consequence of how externally administered testosterone affects the body's hormonal feedback system.
Now, you might be thinking: If TRT is providing the testosterone your body needs, why does testicular shrinkage matter?
Fair question.
For some men, the physical change itself is the main concern. And that's reason enough to bring it up during a medical appointment.
But there's another issue that deserves even more attention: fertility.
Testosterone therapy can substantially reduce sperm production. In some men, sperm counts become extremely low or sperm may temporarily disappear from the ejaculate altogether, a condition known as azoospermia.
That's especially important for men who want to have children, whether that's next year or sometime further down the road.
And here's something that often surprises people: Having normal or even elevated testosterone levels on TRT doesn't mean sperm production is being maintained.
Those are two different processes.
Another consideration is what happens if someone eventually stops testosterone therapy. Natural hormone production may recover, but the timing and extent of recovery vary. Age, underlying hormone function, treatment history, and other individual factors can all influence the outcome.
In other words, TRT can be an effective treatment for testosterone deficiency, but its effects on reproductive function deserve attention before and during treatment.
Human chorionic gonadotropin, or HCG, is a hormone that can act similarly to luteinizing hormone.
Remember LH, the signal from the brain that tells the testes to make testosterone? HCG can activate the same receptors on the testosterone-producing Leydig cells.
That means it can stimulate testosterone production within the testes, even when the body's own LH levels have been suppressed.
And that's why HCG sometimes enters the conversation when men are receiving testosterone therapy.
Instead of supplying additional testosterone directly, HCG acts on the biological pathway involved in natural testicular testosterone production.
It's an important distinction because testosterone levels in the bloodstream and testosterone levels inside the testes aren't necessarily the same.
The latter plays a critical role in sperm production.
HCG has established medical uses, including treatment of certain forms of male hypogonadotropic hypogonadism. Its use alongside TRT specifically to address treatment-related testicular shrinkage or preserve fertility, however, is not an FDA-approved indication.
Still, researchers have explored this approach, and the results offer some useful insight into how HCG works.
One frequently cited study, published in The Journal of Clinical Endocrinology & Metabolism in 2005, examined how HCG affected testosterone production within the testes when the body's natural hormone signaling was suppressed.
Researchers studied 29 healthy men who received testosterone along with different doses of HCG or a placebo.
The results were striking.
In the testosterone-plus-placebo group, intratesticular testosterone levels fell by approximately 94%.
But the men who received HCG experienced substantially less suppression. At one of the doses studied, intratesticular testosterone remained close to baseline levels.
That was an important finding because it demonstrated that HCG could maintain testosterone production within the testes despite suppression of the body's natural LH signaling.
The study lasted only three weeks, and researchers weren't measuring long-term fertility outcomes or whether HCG prevented visible testicular shrinkage.
A separate retrospective study published in 2013 examined 26 men receiving testosterone therapy alongside HCG. Researchers reported that none of the participants became azoospermic during the observed treatment period.
Again, promising findings.
Taken together, these studies support further investigation into HCG's role in maintaining certain aspects of testicular function during TRT. They don't establish that adding HCG will reliably prevent shrinkage or preserve fertility in every patient.
Here's a question that's probably crossed the mind of more than a few men who've been on TRT for a while: What if the shrinkage has already happened?
Is there a way back?
Potentially, depending on what's causing the changes and how the testes respond to treatment.
Because HCG stimulates the cells responsible for testosterone production within the testes, it may be considered in certain clinical situations involving reduced testicular stimulation.
But there's no reliable rule that says adding HCG will restore testicular size within a particular number of weeks or months.
And improvement in testosterone production doesn't necessarily mean that testicular volume or sperm production will return to previous levels.
That's particularly important for men who have been receiving testosterone therapy for a long time or who have underlying reproductive health concerns.
If fertility is part of the picture, a healthcare provider may recommend semen analysis and other testing to better understand current reproductive function.
Some men may require a different treatment approach, including evaluation by a reproductive urologist.
The takeaway? Changes in testicular size aren't necessarily something you have to ignore. But figuring out what to do about them starts with understanding the cause and reviewing the available options with a qualified provider.
If HCG sounds like something worth learning more about, the next question is usually pretty straightforward: How does treatment actually work?
HCG is generally administered by injection, and the dosing schedule depends on the medical indication and the individual's needs.
There isn't one standard HCG protocol proven to prevent testicular shrinkage in every man receiving TRT.
Before considering treatment, a healthcare provider should review the patient's medical history, current testosterone regimen, hormone levels, reproductive goals, and potential contraindications.
For men who want to explore HCG as a testosterone protocol adjunct through a supervised clinic, the process begins with a medical evaluation by a licensed healthcare provider.
Depending on the patient's circumstances, that assessment may involve laboratory testing and a discussion of whether HCG has an appropriate role in their care.
A provider-guided approach also usually includes ongoing monitoring to help clinicians evaluate treatment response and potential adverse effects.
Of course, not everyone who asks about HCG will be an appropriate candidate. A prescription depends on a licensed provider's independent medical judgment and applicable prescribing requirements.
But for men with questions about testicular function while on TRT, understanding the available treatment options is a reasonable place to start.
HCG has its own potential risks, and they're worth understanding before considering treatment.
Because it stimulates testosterone production, it can also influence other hormone levels, including estradiol.
Possible adverse effects include headaches, injection-site reactions, fluid retention, and gynecomastia. Allergic reactions and other adverse effects can also occur.
The risks may vary depending on the individual, the reason for treatment, and whether HCG is being used alongside other hormonal medications.
And while HCG can stimulate testosterone production within the testes, it doesn't replace every function of the hormonal signaling system.
In particular, it doesn't directly replace FSH, which also plays an important role in sperm production.
That helps explain why HCG alone cannot be assumed to preserve fertility during TRT.
For men actively trying to conceive, the treatment discussion may be different from that of someone primarily concerned about changes in testicular size.
In fact, professional guidance advises against prescribing testosterone monotherapy to men interested in current or future fertility. Men planning to conceive should discuss treatment alternatives and fertility-preservation strategies with a qualified specialist.
The goal isn't simply to add another medication to a TRT regimen. It's to understand which approach is medically appropriate for the individual.
Let’s say you're already on TRT, and you've started noticing changes in testicular size. Or maybe you haven't started treatment yet and want to understand what might happen down the road.
Either way, this is a conversation worth having.
Start by asking how testosterone therapy may affect your natural hormone production and reproductive function.
If maintaining fertility matters to you, bring that up early. Your provider may recommend additional evaluation or discuss options other than testosterone monotherapy.
And if you're interested in HCG, ask what the available research actually shows, whether it's appropriate for your circumstances, and what monitoring would be involved.
There's also nothing wrong with asking about the practical details, including cost, injections, possible side effects, and how a clinician would evaluate whether treatment is achieving its intended medical goals.
A good treatment discussion should leave you with a clearer understanding of your options, not the impression that every man needs the same combination of medications.
Because when it comes to hormone therapy, more isn't automatically better.
The right approach depends on what you're treating, what matters to you, and what your medical evaluation reveals.
Testicular shrinkage might not be the first thing men think about when considering testosterone replacement therapy. But it's a recognized possibility, and it's one that deserves a straightforward conversation.
TRT can suppress the hormonal signals responsible for natural testosterone and sperm production. For some men, that suppression is accompanied by changes in testicular size.
HCG offers an interesting option for discussion because it acts on one of those same signaling pathways and can stimulate testosterone production within the testes.
Research has demonstrated this biological effect, although evidence remains limited when it comes to reliably preventing testicular shrinkage or maintaining fertility during TRT.
For men who are concerned about these changes, the answer isn't necessarily to stop testosterone therapy or immediately add another medication.
It's to have a more informed conversation with a healthcare provider who understands both the benefits and the reproductive implications of hormone treatment.
And that's really what individualized TRT care should be about: Understanding the full picture, discussing concerns before they become bigger issues, and making treatment decisions based on your health rather than a one-size-fits-all protocol.
Disclaimer: This article is intended for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Prescription hormone therapies require an individualized evaluation by a licensed healthcare provider and may not be appropriate for everyone. Do not start, stop, or change medication without consulting a qualified healthcare professional.
MBTPG/MF